Clinical Trials Logo

Clinical Trial Summary

This study sought to evaluate an innovative post-acute continuation/transition planning treatment strategy that leveraged an in-person intensive treatment followed by online, videoconferencing-based "booster" sessions for youth with selective mutism (SM). Twenty children between the ages of 4 and 10 and their caregivers were scheduled to participate in an in-person intensive group behavioral treatment (IGBT) for SM and subsequently randomized to receive either (a) six, biweekly, hour-long, videoconferencing-delivered booster sessions or (b) no additional treatment for 12 weeks. Due to COVID-19-related physical distancing restrictions, the study team was unable to provide in-person services. Thus, the clinical trial was converted to an open-trial design focused on evaluating remote treatment options (i.e., remotely delivered caregiver training sessions and/or a remotely delivered IGBT) for these families. All families retained in the study have or will participate(d) in assessments at the following time points: Intake (i.e., 4-5 months prior to the remote IGBT); Baseline (i.e., 1 month prior to the IGBT), Post-IGBT (i.e., 2 weeks following the IGBT), and School Year Follow Up (i.e., 16 weeks following the IGBT).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04291638
Study type Interventional
Source Florida International University
Contact
Status Completed
Phase N/A
Start date March 6, 2020
Completion date December 7, 2020

See also
  Status Clinical Trial Phase
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00554749 - What Treatment Works for Children With Selective Mutism? N/A
Completed NCT04585048 - The Efficacy of Integrated Behavioral Therapy for Selective Mutism N/A
Completed NCT01002196 - Randomised Controlled Treatment Study of Selective Mutism Phase 2
Completed NCT02009839 - Web-Based CBT Protocol for Treatment of Selective Mutism N/A
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Completed NCT02051192 - Brief Behavioral Treatment for Anxiety in Young Children Phase 1/Phase 2
Completed NCT00458198 - Integrated Behavioral Therapy for Treating Children With Selective Mutism N/A
Completed NCT05378711 - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine Phase 2
Completed NCT03612102 - Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism N/A
Completed NCT04233905 - Factors Influencing Selective Mutism